44 results on '"Foekens, John A."'
Search Results
2. Tumour radiosensitivity is associated with immune activation in solid tumours
3. A genome-based model for adjusting radiotherapy dose (GARD): a retrospective, cohort-based study
4. Prognostic Impact of HER2 and ER Status of Circulating Tumor Cells in Metastatic Breast Cancer Patients with a HER2-Negative Primary Tumor
5. Endocrine therapy resistance in estrogen receptor (ER)-positive breast cancer
6. GATA3 mRNA expression, but not mutation, associates with longer progression-free survival in ER-positive breast cancer patients treated with first-line tamoxifen for recurrent disease
7. The use of circulating tumor cells in guiding treatment decisions for patients with metastatic castration-resistant prostate cancer
8. Global proteomic characterization of microdissected estrogen receptor positive breast tumors
9. Efficacy of Cabazitaxel in Castration-resistant Prostate Cancer Is Independent of the Presence of AR-V7 in Circulating Tumor Cells
10. Gene expression profiles of circulating tumor cells versus primary tumors in metastatic breast cancer
11. Ferritin Heavy Chain in Triple Negative Breast Cancer: A Favorable Prognostic Marker that Relates to a Cluster of Differentiation 8 Positive (CD8+) Effector T-cell Response
12. Selection of Bone Metastasis Seeds by Mesenchymal Signals in the Primary Tumor Stroma
13. Allele-Specific, Non-Extendable Primer Blocker PCR (AS-NEPB-PCR) for DNA Mutation Detection in Cancer
14. Clinical value of circulating endothelial cell detection in oncology
15. CD49f-based selection of circulating tumor cells (CTCs) improves detection across breast cancer subtypes
16. Optimized nLC-MS workflow for laser capture microdissected breast cancer tissue
17. Identification, validation and clinical implementation of cancer biomarkers: Translational strategies of the EORTC PathoBiology Group
18. Whole genome profiling on freshly frozen and matching archived and freshly prepared formalin-fixed paraffin-embedded tissues
19. Circulating tumor cells (CTCs): Detection methods and their clinical relevance in breast cancer
20. Latent Bone Metastasis in Breast Cancer Tied to Src-Dependent Survival Signals
21. Identification of a Putative Protein Profile Associated with Tamoxifen Therapy Resistance in Breast Cancer
22. Circulating tumour cell detection on its way to routine diagnostic implementation?
23. Biomarkers for therapeutic efficacy
24. DNA-methylation of the homeodomain transcription factor PITX2 reliably predicts risk of distant disease recurrence in tamoxifen-treated, node-negative breast cancer patients – Technical and clinical validation in a multi-centre setting in collaboration with the European Organisation for Research and Treatment of Cancer (EORTC) PathoBiology group
25. European Organisation for Research and Treatment of Cancer (EORTC) Pathobiology Group standard operating procedure for the preparation of human tumour tissue extracts suited for the quantitative analysis of tissue-associated biomarkers
26. Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer
27. Urokinase-Type Plasminogen Activator and Its Inhibitor Type 1 Predict Disease Outcome and Therapy Response in Primary Breast Cancer
28. Tumor Markers
29. Tumor Tissue Concentrations of the Proteinase Inhibitors Tissue Inhibitor of Metalloproteinases-1 (TIMP-1) and Plasminogen Activator Inhibitor Type 1 (PAI-1) Are Complementary in Determining Prognosis in Primary Breast Cancer
30. Insulin-like growth factor 1 (IGF-1) and urokinase-type plasminogen activator (uPA) are inversely related in human breast fibroblasts
31. 23 Differential susceptibility of primary human breast fibroblasts to TGFβ1 coincides with the proneness of these (myo)fibroblasts to produce uPA in response to factor(s) released by human epithelial carcinoma cells in vitro
32. Multidrug resistance protein in recurrent breast cancer
33. Oncogene amplification and prognosis in breast cancer: Relationship with systemic treatment
34. Cell biological factors associated with the response of breast cancer to systemic treatment
35. The prognostic value of epidermal growth factor receptors, determined by both immunohistochemistry and ligand binding assays, in primary epithelial ovarian cancer: a pilot study
36. Prevalence of amplification of the oncogenes c-myc, HER2/neu, and int-2 in one thousand human breast tumours: Correlation with steroid receptors
37. Quality control of cathepsin-D measurement by the EORTC receptor study group
38. Progesterone, oestradiol, somatostatin and epidermal growth factor receptors on human meningiomas and their CT characteristics
39. Antiproliferative effects of suramin on androgen responsive tumour cells
40. Extraction of nuclear androgen receptors from rat prostate with different reagents
41. Oestradiol enhances doxorubicin uptake and cytotoxicity in human breast cancer cells (MCF-7)
42. Inhibition of nucleic acid and chromatin binding of the rat prostate androgen receptor by pyridoxal phosphate, heparin and cibacron blue
43. Purification of the androgen receptor of sheep seminal vesicles
44. DNA and protein components of nuclear acceptor sites for androgen receptors in the rat prostate
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.